Shop

Showing 361–390 of 429 results

  • CMO CDMO

    Samsung Biologics

    Samsung Biologics is a Contract Development and Manufacturing Organization (CDMO) services company with one of the world’s largest capacity in a single location. They offer development, manufacturing, quality, and biosafety testing services for biologics.

  • Large

    Samsung Pharm. Ind. Co., Ltd.

    Pharmaceutical products

  • Large

    Samyang Biopharmaceutical Corporation

    Drug delivery system (DDS) technology

  • Placeholder
    Large

    Samyang Chemical Industry Co., Ltd.

    Chemical products

  • Venture

    Sanigen

    Sanigen provides a food safety total solution for the manufacture, distribution, and sale of safe food. They strive to contribute to the development of the Korean food industry.

  • Global

    Sanofi-Aventis Korea

    Difficult-to-treat diseases and immunization

  • Global

    Santen Pharmaceutical Korea Co., Ltd

    Ophthalmic products

  • Venture

    SCM Lifescience Co Ltd

    Biopharmaceuticals

  • Diagnostics

    Seegene Co., Ltd.

    In vitro diagnostic (IVD) products

  • Large

    Seongwon Adcock Pharmaceutical Co., Ltd.

    Pharmaceutical products

  • CRO

    SEOUL CRO

    Strategy consulting, regulatory affairs, medical writing, clinical operation, data management, biostatistics, and clinical study reports

  • Large

    Seoulpharm. Co., Ltd

    Pharmaceutical products

  • Venture

    Shaperon

    Shaperon is a clinical stage biotech company developing Novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and Nanobody therapeutics

  • Large

    Shin Poong Pharm. Co., Ltd.

    Active pharmaceutical ingredients (API), intermediates, and pyridine derivatives

  • Large

    Sinil Pharmaceutical Co., Ltd.

    Active pharmaceutical ingredients (APIs), intermediates, and pyridine derivatives

  • Large

    Sinsin Pharmaceutical Co., Ltd.

    Drug delivery devices

  • Venture

    siRNAgen Therapeutics

    siRNAgen’s pioneering SAMiRNA platform harnesses modular chemistry and self-assembly to expand delivery of RNAi beyond the liver and ultimately make treatments easier on patients. The platform’s unique chemistry leverages supramolecular interactions to form a micellar structure with the oligonucleotide at its core. This design allows the incorporation of specific targeting moieties, broadening the delivery possibilities to target tissues.

  • Large

    SK Bioscience Co., Ltd

    Stem cell research

  • Venture

    SMT Bio

    SMT bio Co., Ltd. was founded in 2015 for developing NK cell immuno-therapeutics and now the company is developing the drug to treat rare and refractory cancers such as biliary tract cancer.

  • Placeholder
    Ingredient

    SS Pharm. Co., Ltd

    Active pharmaceutical ingredients (APIs), intermediates, and pyridine derivatives

  • Venture

    STC Bio

    A research-centered company such as stem cell research and development, aging related p62 gene action mechanism and anti-aging product development, new drug development, energy water business and agricultural science research and development, is going to contribute to the mankind and lead the 4th industrial revolution.

  • Venture

    StemLab

  • CMO CDMO

    STGENBIO

    STgen Bio is aiming to contribute to the expansion of the K-Bio global market through cooperation with the leading domestic bio-ventures and companies offering biopharmaceutical manufacturing (CMO).

  • Venture

    STR Biotech Co., Ltd.

    Phagocytosis enhancer for the support treatment of cancer, autoimmune, and other serious diseases

  • Large

    Suheung Co., Ltd

    Manufacturing of capsules

  • Venture

    Sumagen

    Sumagen Co., Ltd. is a biotechnology company and a member of Curo Group. Sumagen holds Exclusive License for Dr. Kang, Chil-Yong’s HIV/AIDS vaccine development and its commercialization. Sumagen is also holder of a Preferred Bidding Rights for the development and subsequent production and marketing for HCV (Hepatitis C Virus) vaccine and the next generation antibiotics of Dr. Heinrich

Scroll to Top